Gene · 5422
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-exome sequencing screening for candidate genes and potential pathogenic variants associated with early-onset high myopia in 47 Chinese families. | Sci Rep | 2025 | 40175531 | PubTator, text mining | PubMed |
| Bioinformatics and experimental approach reveal potential prognostic and immunological roles of key mitochondrial metabolism-related genes in cervical cancer. | Front Oncol | 2025 | 40165902 | PubTator, text mining | PubMed |
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study. | Cancer | 2025 | 40159303 | PubTator, text mining | PubMed |
| Biochemical Mechanisms of Genetic Recombination and DNA Repair. | Annu Rev Biochem | 2025 | 40153609 | PubTator, text mining | PubMed |
| Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database. | Front Pharmacol | 2025 | 40041494 | PubTator, text mining | PubMed |
| Prime Editing: Mechanistic Insights and DNA Repair Modulation. | Cells | 2025 | 39996750 | PubTator, text mining | PubMed |
| Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Sci Rep | 2025 | 39833435 | PubTator, text mining | PubMed |
Is first-line treatment with polatuzumab vedotin-rituximab-cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) for previously untreated diffuse large B-cell lymphoma cost-effective in China? A cost-effectiveness analysis using a Markov model. | BMJ Open | 2025 | 39832983 | PubTator, text mining | PubMed |
| Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder. | Eur J Hum Genet | 2025 | 39616267 | PubTator, text mining | PubMed |
| Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort. | Neuro Oncol | 2025 | 39432559 | PubTator, text mining | PubMed |
| Association of Serum Metabolites with Serum Indices and Preanalytical Factors of Biobanked Serum Samples. | Biopreserv Biobank | 2025 | 38975777 | PubTator, text mining | PubMed |
| In Silico Analysis of Cross-Species Sequence Variability in Host Interferon Antiviral Pathway Proteins and SARS-CoV-2 Susceptibility. | Zoonoses | 2024 | 41816638 | PubTator, text mining | PubMed |
| Identification of POLA1 gene deep intronic mutation confirms diagnosis of X-linked reticulate pigmentary disorder in a Chinese patient. | Indian J Dermatol Venereol Leprol | 2024 | 39635787 | PubTator, text mining | PubMed |
| Proteome profiling of polyomavirus nuclear replication centers using iPOND. | J Virol | 2024 | 39480110 | PubTator, text mining | PubMed |
| Replication-coupled inheritance of chromatin states. | Cell Insight | 2024 | 39391004 | PubTator, text mining | PubMed |
| 53BP1 deficiency leads to hyperrecombination using break-induced replication (BIR). | Nat Commun | 2024 | 39368985 | PubTator, text mining | PubMed |
| Multiplex Loop-Mediated Isothermal Amplification Coupled Lateral Flow Assay for Point-of-Care Detection of Syphilis. | Indian J Microbiol | 2024 | 39282190 | PubTator, text mining | PubMed |
| Insight into the role of stress response and toxic mechanism induced by Chloro-haloacetonitrile in vitro. | Ecotoxicol Environ Saf | 2024 | 39244879 | PubTator, text mining | PubMed |
| The gray boundaries of aberrant shortening of the cellular timekeepers' edges. | EMBO Mol Med | 2024 | 39198716 | PubTator, text mining | PubMed |
| The evolving genetic landscape of telomere biology disorder dyskeratosis congenita. | EMBO Mol Med | 2024 | 39198715 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5422/papers?page=4